Global Inflammation Think Tank

"Inflammation: Shared Pathways in Diverse Diseases" is a  unique multidisciplinary event scheduled to take place on September 24-25, 2021, that will unite inflammation specialists from leading global institutions.

This global inflammation meeting is organized by the Cura Foundation with the educational support of the Worldwide Network for Innovation in Clinical Education and Research (WNICER). It will focus on Building Bridges Among Disciplines to Advance Knowledge and Public Health. The goals of this gathering are to better understand inflammation in diverse diseases, provide a structured assessment for its evaluation and improve therapeutic approaches to modulate inflammatory pathways and processes.

This think tank will include luminaries from different fields with the aim to transcend usual boundaries between specialties, to hasten scientific advances, and accelerate translation to improved health as Inflammation provide a common set of pathways that generate diseases in multiple fields and are being harnessed for novel treatments.


The Cura Foundation (“Cura” or the “Foundation”) is a nonsectarian, nonpartisan, public 501(c)(3) organization with a mission is to improve human health globally. Cura’s objective is to streamline health care delivery and optimize access to care to prevent and vanquish disease, reduce human suffering and increase the quality of life around the world. We aim to advance the development of breakthrough medical technologies, promote preventative measures, encourage interdisciplinary approaches to medicine, improve access to innovation and eliminate social disparities in health care.

At Cura, we #UniteToPrevent and #UniteToCure.



WNICER (Worldwide Network for Innovation in Clinical Education and Research) is a multinational network with the goal to impact chronic conditions through clinical research in order to produce evidence-based trials and interventions that increase our knowledge of health and disease, improving the quality of our health care, and the development of devices and therapies that can directly benefit the patient. WNICER is committed to implementing programs that aim to shorten the time from discovery to patient application with translational research, innovative clinical trials and implementation strategies that impact clinical care that are all supported by a strong continuing medical education program.

Learn more

Meeting Co-Chairs

Peter Munk Chair in Multinational Clinical Trials; Director, Heart & Stroke/Richard Lewar Centre of Excellence; Vice-Chair, Research and Professor of Medicine, Department of Medicine, University of Toronto

Cardiovascular Specialist, Brigham and Women’s Hospital and Mallinckrodt Professor of Medicine, Harvard Medical School

Director of Metabolism and Lipids, Mount Sinai Health System and Professor of Medicine and Cardiology, Icahn School of Medicine at Mount Sinai

President, Cura Foundation and Stem for Life, and Vice President and Director, Science and Faith Foundation (STOQ)


Dean of System Operations for Clinical Sciences,
Chief of the Division of Infectious Diseases and the Dr. George Baehr Professor of Clinical Medicine, Icahn School of Medicine at Mount Sinai

The Rennert Chair of Aging Research, Professor of Medicine and Genetics and
Director, Nathan Shock Center of Excellence in the Biology of Aging, Albert Einstein College of Medicine

Director, Christina Lee Brown Envirome Institute,
University of Louisville

Dean of Translational Genetics and Director, The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai

Professor of Cardiology, Karolinska Institute and Karolinska University Hospital, Stockholm

Distinguished University Professor and Past President,
MD Anderson Cancer Center 

Irene Heinz Given Professor of Immunology and Infectious Diseases, Departments of Immunology and Infectious Diseases and of Molecular Metabolism, Harvard Chan School of Public Health

Professor of Medicine, Chief, Division of Pulmonary, Critical Care, and Sleep Medicine and Senior Director, Clinical Research Strategy and Growth, University of Arizona College of Medicine-Phoenix; Physician Executive Director, Banner - University Lung Institute

Assistant Professor of Medicine and Frances and Kenneth Eisenberg Emerging Scholar, Taubman Medical Research Institute, University of Michigan Medical School

Professor of Experimental Cardiovascular Research, Karolinska Institute and
Secretary General, Royal Swedish Academy of Sciences

Scientific Director,
Istituto Clinico Humanitas;
Emeritus Professor,
Humanitas University 

Professor of Clinical Immunology, Immunogenomics and Inflammation Research Unit, Edouard Herriot Hospital and University of Lyon, France

Chief of Cardiovascular Medicine, Director of Case Cardiovascular Research Institute, Herman K. Hellerstein MD Endowed Chair in Cardiovascular Research, and Professor of Medicine, Case Western Reserve University, University Hospitals (UH) 

Eugene Braunwald Professor of Medicine, Harvard Medical School and Director, Center for Cardiovascular Disease Prevention, Brigham and Women’s Hospital

Editor-in-Chief, New England Journal of Medicine, and Adjunct Professor of Immunology and Infectious Diseases, Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health

Director, Sanders-Brown Center on Aging, University of Kentucky 

Edwin Cohn Professor of Pediatrics, Program in Cellular and Molecular Medicine and Division of Hematology/Oncology, Boston Children’s Hospital and Harvard Medical School

Professor & Chief of Molecular Medicine, UCLA School of Medicine, Director, Institute for Infection & Immunity, Lundquist Institute at Harbor-UCLA and Chair, Medical Sciences, Guthy-Jackson Charitable Foundation